🇺🇸 FDA
Patent

US 7674908

Indazole-carboxamide compounds as 5-HT4 receptor agonists

granted A61PA61P1/00A61P1/10

Quick answer

US patent 7674908 (Indazole-carboxamide compounds as 5-HT4 receptor agonists) held by Theravance, Inc. expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P1/00, A61P1/10, A61P1/14, A61P3/10